KIR3DL2 and myelodysplastic syndrome: In this study, we found that overexpression of PDCD1, TIGIT, CD47, and KIR3DL2 predicted poor OS for MDS patients, and this may indicate that the proteins of these genes might serve as targets for immunotherapy.